Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | MAPT | P10636 | 3/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.52 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4660278 | 1.00 | LMNA (0.67) | LMNAMAPTKMT2AALDH1A1NR1H4 | |
| SCHEMBL4661746 | 1.00 | LMNA (0.67) | LMNAMAPTKMT2AALDH1A1NR1H4 | |
| SCHEMBL4662829 | 1.00 | LMNA (0.67) | LMNAMAPTKMT2AALDH1A1NR1H4 | |
| SCHEMBL4660309 | 1.00 | LMNA (0.67) | LMNAMAPTKMT2AALDH1A1NR1H4 | |
| SCHEMBL4661584 | 1.00 | LMNA (0.67) | LMNAMAPTKMT2AALDH1A1NR1H4 | |
| SCHEMBL4661617 | 1.00 | LMNA (0.67) | LMNAMAPTKMT2AALDH1A1NR1H4 | |
| SCHEMBL4661658 | 1.00 | LMNA (0.67) | LMNAMAPTKMT2AALDH1A1NR1H4 | |
| SCHEMBL4660398 | 0.99 | LMNA (0.68) | LMNAMAPTKMT2AALDH1A1NR1H4 | |
| SCHEMBL4660272 | 0.95 | LMNA (0.70) | LMNAMAPTKMT2AALDH1A1NR1H4 | |
| SCHEMBL4661580 | 0.92 | LMNA (0.71) | LMNAMAPTKMT2AALDH1A1NR1H4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1427697-B1 | SULPHONATION OF PHENOLS | GREAT LAKES CHEMICAL EUROP (CH) | 2008-12-24 | — | — | EP | disclosed |
| US-6936732-B2 | Sulphonation of phenols | ADDIVANT USA, LLC | 2005-08-30 | — | — | US | disclosed |
| US-20050054876-A1 | Sulphonation of phenols | ADDIVANT USA, LLC | 2005-03-10 | — | — | US | disclosed |
| EP-1427697-A1 | SULPHONATION OF PHENOLS | Great Lakes Chemical (Europe) GmbH (CH) | 2004-06-16 | — | — | EP | disclosed |
| WO-2003027063-A1 | SULPHONATION OF PHENOLS | GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) | 2003-04-03 | — | — | WO | disclosed |
| EP-0351615-B1 | PROCESS FOR THE PREPARATION OF 4-ALKOXY-2-HYDROXYBENZOPHENONE-5-SULFONIC ACIDS | BASF Aktiengesellschaft (DE) | 1992-10-28 | — | — | EP | disclosed |
| US-5072034-A | PREPARATION OF 4-ALKOXY-2-HYDROXYBENZOPHENONE-5-SULFONIC ACIDS | BASF AKTIENGESELLSCHAFT (DE) | 1991-12-10 | — | — | US | disclosed |
| EP-0351615-A1 | Process for the preparation of 4-alkoxy-2-hydroxybenzophenone-5-sulfonic acids | BASF Aktiengesellschaft (DE) | 1990-01-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054876-A1 | Sulphonation of phenols | CBR3, C1S, C1R | LMNA 3440/4885MAPT 4859/4885KMT2A 3243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.